BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8282452)

  • 1. Observations on the recent history of drug user counseling.
    Brown BS
    Int J Addict; 1993 Oct; 28(12):1243-55. PubMed ID: 8282452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The counselor in drug user treatment.
    Winick C
    Int J Addict; 1990-1991; 25(12A):1479-502. PubMed ID: 2133581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relating counselor attributes to client engagement in England.
    Simpson D; Rowan-Szal GA; Joe GW; Best D; Day E; Campbell A
    J Subst Abuse Treat; 2009 Apr; 36(3):313-20. PubMed ID: 18835675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating and training substance abuse counselors: a pilot study assessing standardized patients as authentic clients.
    Fussell HE; Lewy CS; McFarland BH
    Subst Abus; 2009; 30(1):47-60. PubMed ID: 19197781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ex-addict versus nonaddict counselors' knowledge of clients' drug use.
    Aiken LS; LoSciuto LA
    Int J Addict; 1985 Mar; 20(3):417-33. PubMed ID: 4018936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paraprofessional versus professional drug abuse counselors: attitudes and expectations of the counselors and their clients.
    LoSciuto L; Aiken LS; Ausetts MA; Brown BS
    Int J Addict; 1984 May; 19(3):233-52. PubMed ID: 6746156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modifying the process of treatment to meet the threat of AIDS.
    Brown BS; Needle RH
    Int J Addict; 1994 Nov; 29(13):1739-52. PubMed ID: 7852000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paraprofessional versus professional drug counselors: diverse routes to the same role.
    Aiken LS; LoSciuto LA; Ausetts MA; Brown BS
    Int J Addict; 1984 Apr; 19(2):153-73. PubMed ID: 6724761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cognitive-existential analysis of counselor responses to HIV-positive substance misusers in an outpatient methadone program and a residential therapeutic community.
    Capone CT; Melchionda R; DeRovira N; Katowsky K; Condren R; Peterson M
    Int J Addict; 1992 May; 27(5):587-611. PubMed ID: 1318275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Needs assessment in substance misuse: a comparison of approaches and case study.
    Simeone RS; Frank B; Aryan Z
    Int J Addict; 1993 Jun; 28(8):767-92. PubMed ID: 8394288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attendance, drug use patterns, and referrals made from North America's first supervised injection facility.
    Tyndall MW; Kerr T; Zhang R; King E; Montaner JG; Wood E
    Drug Alcohol Depend; 2006 Jul; 83(3):193-8. PubMed ID: 16356659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paraprofessional versus professional drug counselors: the progress of clients in treatment.
    Aiken LS; LoSciuto LA; Ausetts MA; Brown BS
    Int J Addict; 1984 Jul; 19(4):383-401. PubMed ID: 6480171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of state requirements for the training of substance abuse and mental health counselors.
    Kerwin ME; Walker-Smith K; Kirby KC
    J Subst Abuse Treat; 2006 Apr; 30(3):173-81. PubMed ID: 16616160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment and services for drug users in Britain.
    Franey C; Power R; Wells B
    J Subst Abuse Treat; 1993; 10(6):561-7. PubMed ID: 8308941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Professional confidence and job satisfaction: an examination of counselors' perceptions in faith-based and non-faith-based drug treatment programs.
    Chu DC; Sung HE
    Int J Offender Ther Comp Criminol; 2014 Aug; 58(8):975-92. PubMed ID: 23788288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of program services on treatment outcomes of patients with comorbid mental and substance use disorders.
    Grella CE; Stein JA
    Psychiatr Serv; 2006 Jul; 57(7):1007-15. PubMed ID: 16816286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Experience of the Treatment Demand Indicator in Europe: A Common Monitoring Tool Across 30 Countries.
    Montanari L; Pirona A; Guarita B; Hedrich D; Mounteney J; Vicente J
    J Stud Alcohol Drugs Suppl; 2019 Jan; Sup 18(18):139-151. PubMed ID: 30681958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using peer, self, and counselor ratings to evaluate treatment progress.
    Czuchry M; Dansereau DF; Sia TL; Simpson DD
    J Psychoactive Drugs; 1998; 30(1):81-7. PubMed ID: 9565211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What are the correlates of substance abuse treatment counselor salaries?
    Olmstead TA; Johnson JA; Roman PM; Sindelar JL
    J Subst Abuse Treat; 2005 Oct; 29(3):181-9. PubMed ID: 16183467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drug users outside medical treatment: methodological and practical aspects].
    Kübler D; Hausser D; Joye D
    Soz Praventivmed; 1996; 41 Suppl 1():S96-104. PubMed ID: 8693822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.